Matta, Komodo
Viallon, Vivian
Botteri, Edoardo
Peveri, Giulia
Dahm, Christina
Nannsen, Anne Østergaard
Olsen, Anja
Tjønneland, Anne
Elbaz, Alexis
Artaud, Fanny
Marques, Chloé
Kaaks, Rudolf
Katzke, Verena
Schulze, Matthias B.
Llanaj, Erand
Masala, Giovanna
Pala, Valeria
Panico, Salvatore
Tumino, Rosario
Ricceri, Fulvio
Derksen, Jeroen W. G.
Nøst, Therese Haugdahl
Sandanger, Torkjel M.
Borch, Kristin Benjaminsen
Quirós, J. Ramón
Castro-Espin, Carlota
Sánchez, Maria-José
Atxega, Amaia Aizpurua
Cirera, Lluís
Guevara, Marcela
Manjer, Jonas
Tin Tin, Sandar
Heath, Alicia
Touvier, Mathilde
Goldberg, Marcel
Weiderpass, Elisabete
Gunter, Marc J.
Freisling, Heinz
Riboli, Elio
Ferrari, Pietro
Funding for this research was provided by:
Institut National du Cancer (INCa) (AAP SHS-E-SP 2020, SHSESP20-071, IARC-2020-2024)
Article History
Received: 19 July 2023
Accepted: 18 March 2024
First Online: 29 May 2024
Declarations
:
: All participants provided written informed consent to participate in the study. Ethical approval was obtained from the participating centres and the International Agency for Research on Cancer (IARC) ethics committee (reference number: IEC 24-08). The EPIC cohort was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: Marc J. Gunter is a member of the editorial board for BMC Medicine. The other authors declare no potential competing interests.<b>IARC disclaimer</b>Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer /World Health Organization.<b>WHO Disclaimer</b>The opinions expressed in this article are those of the authors and do not necessarily reflect the views of the WHO, its representatives, or the countries they represent.